🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase 2 study of HPN-100 in subjects with hepatic encephalopathy ...
Status
Completed
Location
Stanford University Medical Center, Division of Gastroenterology and Hepatology
Start Date
2009-12
Trial ID
NCT00999167
This was an open-label, long-term safety study of HPN-100 (RAVICTI; glycero...
Status
Completed
Location
UCLA Pediatrics/Genetics
Start Date
2010-10-04
Trial ID
NCT01257737
Treatments Being Tested
Arm 1: Primary Objective: • To determine the safety and tolerability of m...
Status
Completed
Location
Covance Clinical Pharmacology, Inc.
Start Date
2010-05
Trial ID
NCT01135680
Treatments Being Tested
We propose to test the effectiveness of the combination of CF pancreatic en...
Status
Terminated
Location
National Jewish Health
Start Date
2018-12-02
Trial ID
NCT02323100
Treatments Being Tested
Byler Disease is the result of a homozygous missense (G308V) mutation in th...
Status
No Longer Available
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT02094222
Treatments Being Tested
Some patients with achromatopsia, an inherited disorder characterized by pa...
Status
Suspended
Location
Columbia University Irving Medical Center
Start Date
2025-04-08
Trial ID
NCT04041232
Treatments Being Tested
This is a randomized, controlled, open-label parallel arm study to assess t...
Status
Completed
Location
University of Florida (UF) - Shands Hospital
Start Date
2018-02-20
Trial ID
NCT03335488
This is a medical research study to test a medication in adult patients wit...
Status
Completed
Location
Children's Hospital of Pittsburgh of UPMC
Start Date
2013-06
Trial ID
NCT01881984
Treatments Being Tested
THRIVE is an observational study that will collect information on patients ...
Status
Terminated
Location
United BioSource Corporation
Start Date
2013-09-25
Trial ID
NCT01948427